ESR1 and breast cancer: Based on the expression of estrogen receptor (ER), progesterone receptor (PR), or human epidermal growth factor receptor-2 (HER2), BC can be divided into ER+ and ER-, PR+ and PR-, or HER2+ and HER2- (Fragomeni et al., 2018).